What is Testagen?

A synthetic tetrapeptide (Lys-Glu-Asp-Gly) studied for endocrine signaling along the pituitary–gonadal axis; all data are preclinical.

Testagen in the library · Bioregulator Peptides · Human Trials · What are peptides?

0 registered trials · 0 indexed papers · 0 human / 5 animal studies

From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.

What it is

Testagen is described as a synthetic tetrapeptide with the sequence Lys-Glu-Asp-Gly (KEDG), an anterior pituitary-derived bioregulator studied for modulating endocrine function, particularly the pituitary–gonadal axis. It belongs to a class of short bioregulatory peptides derived from anterior pituitary extracts.

Preclinical research in avian models is characterized as showing it can normalize thyroid hormone levels in hypophysectomized subjects and modulate endocrine signaling. No human clinical trials are described, and all of the information comes from preclinical research.

More cited research

Related compounds

FAQ

What is Testagen?

A synthetic tetrapeptide (Lys-Glu-Asp-Gly) studied for endocrine signaling along the pituitary–gonadal axis; all data are preclinical.

How many registered human trials study Testagen?

The PeptideWhiz trial index lists 0 registered trials for Testagen.

How much published research exists on Testagen?

By study type, PeptideWhiz counts 0 human and 5 animal studies on Testagen.

Which conditions is Testagen researched for?

No condition pages are linked to this compound yet.

Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).